TCS to transform healthcare delivery for NHS Supply Chain
Tata Consultancy Services secures a five-year deal to modernise NHS core systems and supply chain with cloud and AI, aiming to boost efficiency across the UK healthcare network.
Uncategorized
Wonderla to make Tamil Nadu debut on December 2 with new Chennai park
Built with an investment of over ₹611 crore, the 64.30-acre park (of which 37 acres are currently developed) marks Wonderla’s entry into Tamil Nadu. Located along Old Mahabalipuram Road in Illalur village, the company said the park blends futuristic design…
Amazon’s AWS and Microsoft’s Azure face EU probe into cloud power
A Microsoft spokesperson said that the company stands ready to contribute to the commission’s market inquiry, and a spokesperson for Amazon.com Inc.’s AWS unit said it’s confident regulators will find that the cloud market provides choice and innovation.
S&P 500 eyes longest losing run since August on AI, crypto fears
Technology-heavy Nasdaq 100 futures also slipped 0.3%. Asian and European stock indexes fell, while Bitcoin briefly dropped below $90,000 for the first time in seven months. Meanwhile, a Bank of America Corp. survey showed that fund managers’ cash holdings have…
Nomura says consumption turning a corner, paint worries fading, jewellery and FMCG stabilising
Mihir Shah, Vice President and India Consumer Equity Research Analyst at Nomura, breaks down why disruption fears in the paints sector are easing, how Titan remains resilient despite lab-grown diamond concerns, and why Britannia continues to look strong post Varun…
AstraZeneca Pharma and Sun Pharma enter second brand partnership for SZC in India
AstraZeneca will market the therapy as Lokelma, while Sun Pharma will promote and distribute it as Gimliand. AstraZeneca will continue to retain the intellectual property rights for SZC. Shares of Astrazeneca Pharma India Ltd ended at ₹9,132.00, down by ₹23.10,…
Marksans Pharma’s UK arm gets MHRA nod for pain-relief tablets
Marksans Pharma’s UK subsidiary Relonchem has received MHRA authorisation to market 250 mg and 500 mg Mefenamic Acid tablets.
Bombay Burmah terminates agreement with MSTC Ltd, stock soars 10%
In compliance with SEBI regulations, Bombay Burmah informed the stock exchanges of this development and also clarified that there is no shareholding between the two companies involved and that MSTC is not a related party of Bombay Burmah Trading Corporation.
Cosmo, Glenmark secure EU approval for acne drug Winlevi; to launch in 15 countries
The approval follows a positive opinion from the European Medicines Agency’s drug advisory panel in August.
BLS International bags 5-year global visa processing contract from Slovak Republic
BLS International has won a five-year mandate from the Slovak Republic to set up and operate visa application centres across 80+ countries.